Versant Ventures is a venture capital and private equity firm investing in biopharmaceuticals, biotechnology platforms, specialty pharmaceuticals, healthcare services, and healthcare information technology companies. The firm is headquartered in Menlo Park, California and was founded in 1999 by Barbara Lubash, Brian Atwood, Donald B. Milder, Rebecca Robertson, Samuel Colella, and William Link. Versant Ventures makes debt, early stage, late stage, and private equity investments. According to the firms website they have $3.2 billion under management, 34 initial public offerings, and 42 mergers & acquisitions.
Notable exits made by Versant Ventures include: Adverum Biotechnologies, Akero, BlueRock Therapeutics, Ceterix Orthopaedics, CymaBay Therapeutics, Forsight Vision4, Gritstone Oncology, NeuWave Medical, Okairos, Twelve, and WaveTec Vision.